BONESUPPORT announced that the FDA has requested additional biocompatibility data for CERAMENT V, extending the deadline for the company's complete response to October. The regulatory path for CERAMENT V has already been lengthy, and today’s announcement adds another step to the process. We continue to forecast a potential approval by the end of Q4 2026 or during Q1 2027.
LÄS MER
